Resultados da busca - ADAPT Investigators

Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial. por Bryce E Haac, Nathan N O'Hara, Theodore T Manson, Gerard P Slobogean, Renan C Castillo, Robert V O'Toole, Deborah M Stein, ADAPT Investigators

Obter o texto integral

ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial por Justin T. Denholm, Balasubramanian Venkatesh, Joshua Davis, Asha C. Bowen, Naomi E. Hammond, Vivekanand Jha, Grace McPhee, Zoe McQuilten, Matthew V. N. O’Sullivan, David Paterson, David Price, Megan Rees, Jason Roberts, Mark Jones, James Totterdell, Thomas Snelling, Nanette Trask, Susan Morpeth, Steven YC Tong, on behalf of the ASCOT ADAPT investigators

Obter o texto integral

Venous thromboembolism testing practices after orthopaedic trauma: prophylaxis regimen does not influence testing patterns por Bryce E. Haac, MD, Nathan N. O'Hara, PhD, MHA, Elliott R. Haut, MD, MPH, Theodore T. Manson, MD, Gerard P. Slobogean, MD, Robert V. O'Toole, MD, Deborah M. Stein, MD, MPH, ADAPT Investigators, Herman Johal, Richard Van Besien, Peter Z. Berger, George B. Reahl, Dimitrius Marinos, Yasmin Degani, Daniel Mascarenhas, Daniel Connelly, Thomas M. Scalea

Obter o texto integral